> One tiny undiscovered biotech gem making waves this weekend is going
> to be featured next week (July 8th) on NBC Television and it could
> literally explode like CTIC, DNDN and so many other small cap
> biotechs. Click right here for the news release referencing the July
> 8th @ 12pm EDT episode on NBC featuring Viral Genetics (VRAL)-

> http://www.cnbc.com/id/31569575

> Viral Genetics (VRAL) is a biotechnology company developing the VGV-1
> injectable drug for the treatment of HIV/AIDS.

> Check out this amazing video documentary on Viral Genetics and the
> VGV-1 injectable drug during Phase I, II and III clinical trials in
> South Africa @http://www.youtube.com/watch?v=Jf1mQ6cxQNghttp://bit.ly/LBPie

> This is a pretty unique (and hopefully lucurative) situation to find
> outabout the show before it airs.

> The reason I started buying shares was because of the television show
> but I’m actually considering letting some of my shares ride for like
> 2+ years because VRAL hasn’t even announced their IND yet or their FDA
> Phase I initiation yet in the United States.

> And do you want to know one of the the best parts? Although Wall
> Street isn’t valuing the stock too well because they haven’t entered
> into FDA trials at the moment, VRAL has already completed 5 successful
> trials including Phases I, III & III in South Africa (HIV Capital of
> the World).

> This leads me to believe it could be a prime drug for FDA Fast Track
> Approval so what would normally take 4-6 years for FDA Approval could
> be a lot less (but of course that’s just my speculation).

> Good luck to all!